首页> 外文期刊>Nature >Non - homeostatic body weight regulation through a brainstem-restricted receptor for GDF15
【24h】

Non - homeostatic body weight regulation through a brainstem-restricted receptor for GDF15

机译:通过脑干限制的GDF15受体进行非稳态体重调节

获取原文
获取原文并翻译 | 示例
       

摘要

Under homeostatic conditions, animals use well-defined hypothalamic neural circuits to help maintain stable body weight, by integrating metabolic and hormonal signals from the periphery to balance food consumption and energy expenditure(1,2). In stressed or disease conditions, however, animals use alternative neuronal pathways to adapt to the metabolic challenges of altered energy demand(3). Recent studies have identified brain areas outside the hypothalamus that are activated under these 'non-homeostatic' conditions(4-6), but the molecular nature of the peripheral signals and brain-localized receptors that activate these circuits remains elusive. Here we identify glial cell-derived neurotrophic factor (GDNF) receptor alpha-like (GFRAL) as a brainstem-restricted receptor for growth and differentiation factor 15 (GDF15). GDF15 regulates food intake, energy expenditure and body weight in response to metabolic and toxin-induced stresses; we show that Gfral knockout mice are hyperphagic under stressed conditions and are resistant to chemotherapy-induced anorexia and body weight loss. GDF15 activates GFRAL-expressing neurons localized exclusively in the area postrema and nucleus tractus solitarius of the mouse brainstem. It then triggers the activation of neurons localized within the parabrachial nucleus and central amygdala, which constitute part of the 'emergency circuit' that shapes feeding responses to stressful conditions(7). GDF15 levels increase in response to tissue stress and injury, and elevated levels are associated with body weight loss in numerous chronic human diseases(8,9). By isolating GFRAL as the receptor for GDF15-induced anorexia and weight loss, we identify a mechanistic basis for the non-homeostatic regulation of neural circuitry by a peripheral signal associated with tissue damage and stress. These findings provide opportunities to develop therapeutic agents for the treatment of disorders with altered energy demand.
机译:在稳态条件下,动物通过整合来自周围的新陈代谢和激素信号来平衡食物消耗和能量消耗(1,2),使用明确的下丘脑神经回路来帮助维持稳定的体重。然而,在压力或疾病条件下,动物使用替代性神经元途径来适应能量需求变化的代谢挑战(3)。最近的研究已经确定了在这些“非稳态”条件下激活的下丘脑外的大脑区域(4-6),但是激活这些电路的外围信号和大脑定位受体的分子本质仍然难以捉摸。在这里,我们确定神经胶质细胞源性神经营养因子(GDNF)受体α样(GFRAL)作为生长和分化因子15(GDF15)的脑干限制受体。 GDF15调节食物摄入,能量消耗和体重,以应对新陈代谢和毒素引起的压力;我们表明,Gfral基因敲除小鼠在压力条件下是高食性的,并且对化疗引起的厌食和体重减轻具有抵抗力。 GDF15激活表达GFRAL的神经元,该神经元仅位于小鼠脑干的rerema和tractus solitarius区域。然后,它触发了位于臂旁核和中央杏仁核内的神经元的激活,这些神经元构成了``紧急回路''的一部分,该回路形成了对应激条件的进食反应(7)。在许多慢性人类疾病中,GDF15水平随组织压力和损伤而增加,而水平升高与体重减轻相关(8,9)。通过隔离GFRAL作为GDF15诱导的厌食和体重减轻的受体,我们确定了与组织损伤和压力相关的周围信号对神经回路进行非稳态调节的机制基础。这些发现为开发用于治疗能量需求改变的疾病的治疗剂提供了机会。

著录项

  • 来源
    《Nature》 |2017年第7675期|255-259|共5页
  • 作者单位

    NGM Biopharmaceut, San Francisco, CA 94080 USA;

    NGM Biopharmaceut, San Francisco, CA 94080 USA;

    NGM Biopharmaceut, San Francisco, CA 94080 USA;

    NGM Biopharmaceut, San Francisco, CA 94080 USA;

    NGM Biopharmaceut, San Francisco, CA 94080 USA;

    NGM Biopharmaceut, San Francisco, CA 94080 USA;

    NGM Biopharmaceut, San Francisco, CA 94080 USA;

    NGM Biopharmaceut, San Francisco, CA 94080 USA|Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA;

    NGM Biopharmaceut, San Francisco, CA 94080 USA;

    NGM Biopharmaceut, San Francisco, CA 94080 USA;

    NGM Biopharmaceut, San Francisco, CA 94080 USA;

    NGM Biopharmaceut, San Francisco, CA 94080 USA;

    NGM Biopharmaceut, San Francisco, CA 94080 USA;

    NGM Biopharmaceut, San Francisco, CA 94080 USA;

    NGM Biopharmaceut, San Francisco, CA 94080 USA;

    NGM Biopharmaceut, San Francisco, CA 94080 USA;

    NGM Biopharmaceut, San Francisco, CA 94080 USA;

    NGM Biopharmaceut, San Francisco, CA 94080 USA;

    NGM Biopharmaceut, San Francisco, CA 94080 USA;

    NGM Biopharmaceut, San Francisco, CA 94080 USA|BioMarin Pharmaceut Inc, San Rafael, CA 94901 USA;

    XTAL Biostruct, 12 Michigan Dr, Natick, MA 01760 USA;

    XTAL Biostruct, 12 Michigan Dr, Natick, MA 01760 USA;

    Merck Res Labs, Kenilworth, NJ 07033 USA;

    Merck Res Labs, Kenilworth, NJ 07033 USA;

    NGM Biopharmaceut, San Francisco, CA 94080 USA;

    NGM Biopharmaceut, San Francisco, CA 94080 USA;

    NGM Biopharmaceut, San Francisco, CA 94080 USA;

    NGM Biopharmaceut, San Francisco, CA 94080 USA;

    NGM Biopharmaceut, San Francisco, CA 94080 USA;

    NGM Biopharmaceut, San Francisco, CA 94080 USA;

    NGM Biopharmaceut, San Francisco, CA 94080 USA|23andMe Inc, San Francisco, CA 94080 USA;

    NGM Biopharmaceut, San Francisco, CA 94080 USA;

    NGM Biopharmaceut, San Francisco, CA 94080 USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号